Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
When Itching Hurts: Quality of Life Disruption in CKD-aP
Nancy Helou, PhD
Steven Fishbane, MD
What You Don’t See: A Patient’s View of Living with CKD-aP
Gabapentinoids: Safety Considerations and Downstream Outcomes
Winning the CKD-aP Battle: A United Physician-Nurse Front
Spotlight on Assessment: Tools That Capture CKD-aP
Itching for Answers: Holistic CKD-aP Care
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
CKD-aP Uncovered Prevalence & Pathophysiology
Reading Between the Lines: What PROMs Reveal About Itch
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD
Julio Núñez, MD, PhD
Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
Brendon Neuen, MBBS, PhD
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Chee Kay Cheung, MBChB, MRCP, PhD
Claudia Seikrit, MD
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.